A. Lincoff

发表

Utilization of catheterization and revascularization procedures in patients with non‐ST segment elevation acute coronary syndrome over the last decade

C. Cannon, K. Mahaffey, G. Levine, 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Successful treatment of aortic root dissection complicated with extensive myocardial infarction using the total artificial heart

N. Smedira, L. Svensson, M. Shishehbor, 2017, Journal of surgical case reports.

Impact of anticoagulation regimen prior to revascularization in patients with non‐ST‐segment elevation acute coronary syndromes: The ACUITY trial

S. Steinhubl, G. Stone, W. Desmet, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest

S. Ellis, U. Khot, R. Puri, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Interaction Between Race and Income on Cardiac Outcomes After Percutaneous Coronary Intervention

S. Ellis, U. Khot, R. Puri, 2022, Journal of the American Heart Association.

Combined antegrade-retrograde intervention to improve chronic total occlusion recanalization in high-risk critical limb ischemia.

M. Shishehbor, M. Maier, P. Monteleone, 2014, Annals of vascular surgery.

Stent‐assisted detachable coil embolization of pseudoaneurysms in the coronary circulation

S. Ellis, S. Kapadia, A. Lincoff, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions

P. Teirstein, E. Topol, A. Lincoff, 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Drug‐eluting stents versus bare‐metal stents for treatment of bare‐metal in‐stent restenosis

Inder Singh, M. Shishehbor, Eiran Z. Gorodeski, 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Percutaneous coronary revascularization in coronary artery disease: Lessons from a single center experience

E. Tuzcu, S. Ellis, M. Shishehbor, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? Yes

A. Lincoff, J. Exaire, A. Lincoff, 2004, Journal of thrombosis and haemostasis : JTH.

Clinical outcomes of drug‐eluting versus bare‐metal in‐stent restenosis

Inder Singh, M. Shishehbor, Eiran Z. Gorodeski, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.

D. Mozaffarian, P. Ridker, P. Barter, 2020, JAMA.

Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long‐Term Mortality After Noncardiac Vascular Surgery

S. Ellis, A. Lincoff, S. Nissen, 2017, Journal of the American Heart Association.

Impact of a Comprehensive ST‐Segment–Elevation Myocardial Infarction Protocol on Key Process Metrics in Black Americans

U. Khot, Anirudh Kumar, A. Krishnaswamy, 2023, Journal of the American Heart Association.

Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes

D. Grobbee, L. Rydén, J. Tardif, 2018, Diabetes & vascular disease research.

Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).

G. Stone, A. Lincoff, R. Mehran, 2014, JACC. Cardiovascular interventions.

Magnitude and consequences of missing the acute infarct-related circumflex artery.

A. Lincoff, A. Krishnaswamy, V. Menon, 2009, American heart journal.

Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification.

E. Topol, U. Khot, Monica B. Khot, 2003, JAMA.

Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door‐to‐balloon time

S. Ellis, S. Kapadia, U. Khot, 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial

M. Shao, J. Kastelein, A. Lincoff, 2019, JAMA cardiology.

Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients.

P. Libby, P. Ridker, J. Kastelein, 2023, JAMA.

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile.

E. Topol, S. Ellis, A. Lincoff, 1992, Journal of the American College of Cardiology.

Percutaneous support devices for high risk or complicated coronary angioplasty.

E. Topol, S. Ellis, A. Lincoff, 1991, Journal of the American College of Cardiology.

Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis

S. Nissen, E. Kaluski, Nishant P. Shah, 2018, European journal of preventive cardiology.

CORONARY ARTERY DISEASE Original Studies Real-World Bare Metal Stenting: Identification of Patients at Low or Very Low Risk of 9-Month Coronary Revascularization

Deepak L. Bhatt, E. Topol, E. Tuzcu, 2004 .

Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High‐Risk Vascular Disease: Insights From the ACCELERATE Trial

A. Lincoff, S. Nissen, E. McErlean, 2019, Journal of the American Heart Association.

Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction.

L. Deckelbaum, P. Ridker, S. Pocock, 2020, American heart journal.

Managing adverse effects and drug–drug interactions of antiplatelet agents

A. Lincoff, Arun Kalyanasundaram, M. Lincoff, 2011, Nature Reviews Cardiology.

Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting.

E. Topol, S. Ellis, A. Lincoff, 2002, The American journal of cardiology.

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

J. Kastelein, J. Jukema, W. Koenig, 2014, JAMA.

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

James E. Tcheng, Christopher J. White, Norman L. Stockbridge, 2018, Circulation.

Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial

S. Kashyap, A. Lincoff, S. Nissen, 2019, Diabetes & vascular disease research.

Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis

B. Hoogwerf, A. Lincoff, Y. Qu, 2016, Cardiovascular Diabetology.

Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model.

E. Topol, X. Zhou, A. Lincoff, 2001, Journal of the American College of Cardiology.

Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions.

E. Topol, A. Lincoff, J. Tcheng, 2004, The American journal of cardiology.

Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting.

E. Tuzcu, S. Ellis, M. Shishehbor, 2013, Journal of the American College of Cardiology.

Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators.

E. Tuzcu, S. Ellis, M. Shishehbor, 2011, JACC. Cardiovascular interventions.

The use and limitations of unfractionated heparin.

Christopher P Cannon, Amar Krishnaswamy, C. Cannon, 2010, Critical pathways in cardiology.

Is clopidogrel cardiovascular medicine's double-edged sword?

A. Lincoff, A. Bavry, A. Lincoff, 2006, Circulation.

Direct Thrombin Inhibitors in Acute Coronary Syndromes

A. Lincoff, T. Taigen, James E. Harvey, 2010 .

Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial.

J. S. St. John, A. Lincoff, S. Nissen, 2020, JAMA cardiology.

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS‐CoV‐2 associated myocardial injury with heightened inflammation (canakinumab in Covid‐19 cardiac injury: The three C study)

Ossama K. Abou Hassan, A. Lincoff, S. Nissen, 2020, Clinical cardiology.

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High‐Risk Vascular Disease Treated With Statin Therapy

J. S. St. John, A. Lincoff, S. Nissen, 2019, Journal of the American Heart Association.

Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration.

A. Lincoff, Robert A. Harrington, William R. Hiatt, 2008, Circulation.

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

D. Grobbee, L. Rydén, J. Tardif, 2018, Diabetes Care.

Cardiovascular Safety Evaluation in the Development of New Drugs for Diabetes Mellitus

A. Lincoff, V. Menon, A. Lincoff, 2014, Circulation.

CORONARY ARTERY DISEASE Original Studies Utilization of Catheterization and Revascularization Procedures in Patients With Non-ST Segment Elevation Acute Coronary Syndrome Over the Last Decade

C. Cannon, K. Mahaffey, K. Fox, 2005 .

Clinical risk factors for ischemic complications after percutaneous coronary interventions: Results from the EPIC trial

R. Califf, E. Topol, S. Ellis, 1999 .

Intravenous Direct Thrombin Inhibitors

A. Lincoff, F. Philip, A. Lincoff, 2012 .

Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis.

R. Califf, E. Topol, A. Lincoff, 2000, The American journal of cardiology.

Coronary spasm and vasomotor dysfunction as a cause of MINOCA.

R. Gulati, A. Lincoff, J. Zieminski, 2024, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.